These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4216916)

  • 1. [Neutralization of the sputum in newly detected patients with pulmonary tuberculosis treated during the years 1967 to 1970].
    Panajotović H; Marsenić B
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():105-9. PubMed ID: 4216916
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of ethambutol and rifampicin on sputum conversion in chronically infectious patients].
    Juchniewicz M; Radecki A; Kowalczyk H; Grzywacz W
    Gruzlica; 1974 May; 42(5):397-400. PubMed ID: 4464226
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
    Golanov VS; Bogdalova VE; Andreev LP; Losin EI; Ushakova AG; Meshcheriakov VG; Bondin SV
    Probl Tuberk; 1991; (12):27-8. PubMed ID: 1803368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE
    Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
    [No Abstract]   [Full Text] [Related]  

  • 9. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monotherapy of chronic pulmonary tuberculosis using Rimactan. Report on a 3-month-long therapeutic series].
    Hofmann F
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1363-7. PubMed ID: 4971389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE; Kiazimova LM
    Probl Tuberk; 1986; (9):31-4. PubMed ID: 3097632
    [No Abstract]   [Full Text] [Related]  

  • 13. [Condition of the liver in patients with chronic pulmonary tuberculosis receiving a combination of antibacterial drugs including rifampicin and ethambutol].
    Kondrat'eva VI; Umarova MK; Arifkhanova SI
    Probl Tuberk; 1977; (2):35-40. PubMed ID: 866309
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bacteriological analysis of patients treated with rifampicin and ethambutol under hospital and ambulatory conditions in Poznan in the years 1969-1972 with special reference to methods of patient surveillance].
    Krukowska-Grzezińska A; Chodera B; Klimczyk M; Kańczugowski W; Kubiaczyk T
    Gruzlica; 1974 May; 42(5):420-3. PubMed ID: 4464231
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in renal transplant recipients.
    Tantawichien T; Suwangool P; Suvanapha R
    Transplant Proc; 1994 Aug; 26(4):2187-8. PubMed ID: 8066715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of resumption of treatment with rifampin and ethambutol in patients with recurrent pulmonary tuberculosis].
    Jozefovics F; Barbu Z; Bálinth E; Ovári AM
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):177-84. PubMed ID: 212815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Australian rifampicin trial.
    Proust A; Evans C
    Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.